|
gptkb:Nucleophosmin
|
gptkb:tumor_suppressor
|
|
gptkb:Tumor_suppressor_p53-binding_protein_1
|
genome stability maintenance
|
|
gptkb:PKM2_isoform
|
promotes aerobic glycolysis
|
|
gptkb:Tumor_suppressor_p53-binding_protein_1
|
tumor suppression
|
|
gptkb:PKM2
|
gptkb:Warburg_effect
|
|
gptkb:L1CAM
|
poor prognosis marker
|
|
gptkb:4E-BP1
|
dysregulation associated with tumorigenesis
|
|
gptkb:DPP-4_enzyme
|
potential therapeutic target
|
|
gptkb:L1CAM
|
tumor progression
|
|
gptkb:E6-Associated_Protein
|
degradation of p53 tumor suppressor protein
|
|
gptkb:phosphoglycerate_kinase_1_protein
|
promotes tumor growth
|
|
gptkb:phosphoglycerate_kinase_1_protein
|
overexpressed in several cancers
|
|
gptkb:PKM2
|
tumor metabolism
|
|
gptkb:p21Cip1
|
can be overexpressed in some cancers
|
|
gptkb:L1CAM
|
metastasis
|
|
gptkb:CDH1
|
gptkb:tumor_suppressor
|
|
gptkb:Nucleophosmin
|
gptkb:oncoprotein
|
|
gptkb:HER2/neu
|
gptkb:tumor_suppressor
|
|
gptkb:PKM2_isoform
|
supports Warburg effect
|
|
gptkb:B-cell_lymphoma_2
|
gptkb:tumor_suppressor
|